ABBADESSA, GIANMARCO
 Distribuzione geografica
Continente #
EU - Europa 515
NA - Nord America 400
AS - Asia 97
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.016
Nazione #
US - Stati Uniti d'America 399
IE - Irlanda 259
IT - Italia 83
GB - Regno Unito 56
DE - Germania 52
SG - Singapore 45
CN - Cina 38
UA - Ucraina 12
FI - Finlandia 11
GR - Grecia 11
BE - Belgio 8
IN - India 7
SE - Svezia 7
CZ - Repubblica Ceca 6
FR - Francia 5
KR - Corea 3
MA - Marocco 3
LB - Libano 2
NL - Olanda 2
EU - Europa 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
LU - Lussemburgo 1
MX - Messico 1
RU - Federazione Russa 1
Totale 1.016
Città #
Dublin 259
Chandler 65
Roxbury 33
Princeton 32
Singapore 28
Cambridge 26
New York 24
Jacksonville 19
Bremen 18
Caserta 15
Ann Arbor 13
Medford 13
Boardman 12
Munich 11
Beijing 10
Milan 10
Brussels 8
Naples 8
Des Moines 7
Grafing 6
Lappeenranta 6
Pasadena 6
Brno 5
Helsinki 5
Redwood City 5
Wilmington 5
Nanjing 4
Norwalk 4
Rome 4
Darmstadt 3
Hyderabad 3
Lviv 3
Meknes 3
Norwich 3
Pune 3
Rockville 3
Athens 2
Atlanta 2
Falconara Marittima 2
Groningen 2
Hebei 2
Houston 2
Jinan 2
Nanchang 2
Nutley 2
San Mateo 2
Sant'antimo 2
West Jordan 2
Ashburn 1
Battipaglia 1
Berlin 1
Brdo 1
Catania 1
Changsha 1
Collegeville 1
Elk Grove Village 1
Fairfield 1
Ferrandina 1
Guangzhou 1
Hanover 1
Jakarta 1
Lanzhou 1
Lurago D'erba 1
Luxembourg 1
L’Aquila 1
Napoli 1
New Haven 1
Santa Clara 1
Shenyang 1
Sulmona 1
Suri 1
Taiyuan 1
Woodbridge 1
Wuhan 1
Yoshkar-ola 1
Zanjan 1
Zhengzhou 1
Totale 735
Nome #
Atypical Progressive Multifocal Leukoencephalopathy in a Kidney Transplant Recipient With Improving Symptoms After Immunocompetence Recovery 58
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 51
Telemedicine application to headache: a critical review 48
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 40
e-Health and multiple sclerosis: An update 39
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 36
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 36
Disability assessment using Google Maps 34
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 34
Social Media and Multiple Sclerosis in the Posttruth Age. 33
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 31
Source of medical information and behavioral seeking patterns in patients affected with Friedreich’s ataxia and their caregivers: a survey study 30
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 29
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 29
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 27
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 27
Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report 26
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic 26
Public engagement and neurology: An update 25
Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online. 24
Progressive multifocal leukoencephalopathy presenting with bilateral myoclonus: a case report 23
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 22
Readability Analysis of Online Headache and Migraine Information 22
Paraneoplastic syndrome or immune-related adverse event? A case of rhomboencephalitis in a patient treated with Pembrolizumab 22
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis 22
Hemostasis Components as Therapeutic Targets in Autoimmune Demyelination 22
Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosis 21
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis 20
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 19
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 19
Heidenhain variant of Creutzefeldt-Jackob disease in a patient carrying the V210I mutation with asymmetric MRI abnormalities 18
How to manage with telemedicine people with neuromuscular diseases? 18
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 17
The Use of Social Media and Digital Devices Among Italian Neurologists 16
Digital therapeutics in neurology 15
Digital work engagement among Italian neurologists 14
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles 13
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 12
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 11
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 11
Viral pericarditis following ocrelizumab in a multiple sclerosis patient 10
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 10
Pain, quality of life, and religiosity in people with multiple sclerosis 9
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression 5
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learning 5
Editorial: Bridging the gap between basic neurosciences and clinical neuroimmunology 4
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 3
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab 2
Totale 1.088
Categoria #
all - tutte 7.550
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.550


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202076 8 3 1 8 1 1 7 2 15 7 20 3
2020/202166 2 0 2 12 12 1 10 2 1 4 11 9
2021/2022232 2 15 4 4 57 15 2 3 17 5 22 86
2022/2023398 61 12 9 10 33 16 2 10 213 5 11 16
2023/2024293 16 11 21 13 77 39 13 5 7 4 11 76
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 1.088